Trade-Ideas LLC identified

ICU Medical

(

ICUI

) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified ICU Medical as such a stock due to the following factors:

  • ICUI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $16.2 million.
  • ICUI has traded 112,443 shares today.
  • ICUI is down 3% today.
  • ICUI was up 5.4% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ICUI with the Ticky from Trade-Ideas. See the FREE profile for ICUI NOW at Trade-Ideas

More details on ICUI:

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. ICUI has a PE ratio of 46. Currently there are 3 analysts that rate ICU Medical a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for ICU Medical has been 160,500 shares per day over the past 30 days. ICU Medical has a market cap of $1.7 billion and is part of the health care sector and health services industry. The stock has a beta of -0.08 and a short float of 4.5% with 4.18 days to cover. Shares are up 36.9% year-to-date as of the close of trading on Friday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates ICU Medical as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.

Highlights from the ratings report include:

  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income increased by 130.9% when compared to the same quarter one year prior, rising from $5.88 million to $13.57 million.
  • ICUI's revenue growth trails the industry average of 35.7%. Since the same quarter one year prior, revenues slightly increased by 6.5%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • ICUI has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 14.32, which clearly demonstrates the ability to cover short-term cash needs.
  • The gross profit margin for ICU MEDICAL INC is rather high; currently it is at 57.48%. It has increased from the same quarter the previous year. Along with this, the net profit margin of 16.19% is above that of the industry average.
  • Powered by its strong earnings growth of 118.42% and other important driving factors, this stock has surged by 56.89% over the past year, outperforming the rise in the S&P 500 Index during the same period. Looking ahead, the stock's sharp rise over the last year has already helped drive it to a level which is relatively expensive compared to the rest of its industry. We feel, however, that other strengths this company displays justify these higher price levels.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.